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Purpose: Pharmacy dispensing databases provide a comprehensive source of data on medicines use free
from many of the biases inherent in administrative databases. There are challenges associated with using
pharmacy databases however. This paper describes the methods we used, and their performance, so that
other researchers considering using pharmacy databases may beneﬁt from our experiences.
Methods: Data were collected from all nine pharmacy dispensing databases in an isolated New Zealand
town for the period October 2005–September 2006. Probabilistic record matching was used to link indi-
viduals across pharmacies. Patient addresses from the pharmacy data were geo-located to small areas so
an area measure of socioeconomic deprivation could be assigned. Medicines were coded according to the
ATC-DDD drug classiﬁcation system.
Results: Data on 619,264 dispensings were collected. Record matching reduced an initial pool of individ-
uals from 54,484 to 38,027. Socioeconomic deprivation ranks were assigned for 30,972 (93%) of the
33,375 unique addresses identiﬁed, or 36,048 (95%) of individuals. ATC codes were assigned to
613,490 (99%) of the dispensings, with DDDs assigned to 561,223 (91%). Overall, 93% of dispensing
records had complete demographic and drug information.
Conclusions: The methods described in this paper generated a rich dataset for medicines use research.
These methods, while initially resource-intensive, can to a great extent be automated and applied to
other locations, and will hopefully prove useful to other researchers facing similar challenges with using
pharmacy databases. However, it is difﬁcult to envisage these methods being viable on a long-term or
national scale.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Medicines are a front-line medical intervention. They account
for large portions of health care expenditure in OECD countries
[1,2] and are a signiﬁcant mediator of health status [3,4]. As such,
it is important that the distribution and effects of medicines are
understood so that their health beneﬁts are both optimal and equi-
table, and their use affordable to modern health systems.
In many countries, researchers are reliant on medicines subsidi-
sation data for population-level drug utilisation studies (see [5,6]
for examples). Although the precise details of the various subsidi-
sation schemes differ across countries (and even states), differen-ll rights reserved.
acy, University of Otago, P.O.
orsburgh).tial under-capture of dispensings depending on the coverage of
the scheme is a common issue [7,8]. Other schemes, such as the
United Kingdom’s Prescription Analysis and Cost (PACT) system,
do capture all dispensings but lack socio-demographic information
on the patient [9]. These limitations place restrictions on the types
of research which can be performed using these data. For example,
research may only cover those medicines or people known to be
well-captured by the scheme. Drug utilisation studies on medi-
cines use in the elderly are a good example of this.
A similar situation exists in New Zealand. Much of the drug util-
isation research performed in New Zealand has used data from the
Pharmaceuticals Collection database (known as ‘Pharms’). Pharms
is maintained by the Ministry of Health and the Pharmaceutical
Management Agency (PHARMAC), and contains records of dispen-
sings where the Government has made a contribution to the cost of
(or ‘subsidised’) the medicine. In New Zealand, the Government
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ers are often expected to pay a certain ﬁxed amount towards the
cost of a medicine dispensing. This amount was, until the mid-
2000s, up to NZ$15 per item but is now normally NZ$3 (and some-
times nothing) and has varied according to the patient’s age,
income and health status. If the medicine is particularly cheap,
the patient’s payment may actually cover the cost of the medicine.
In these cases the medicine will not be recorded in Pharms, as the
Government’s contribution was nil. Likewise, Pharms will not con-
tain records for medicines where the Government does not con-
tribute to the cost at all (as for some ‘lifestyle’ medicines like
Xenical). Precisely what level of bias this introduces is unknown
[10]. Even when patient payments are low (say NZ$3), certain com-
mon medicines may still be sufﬁciently inexpensive that they cost
less than the patient payment. Antibiotics are a good example of
this [11]. Previous research has demonstrated the uneven capture
of Pharms, with some medicines found to be well-captured while
others are not [11,12]. Longitudinal studies are also made difﬁcult,
since changes in the subsidisation status of a medicine may have a
profound effect on whether it is captured by Pharms.
Pharmacy dispensing databases have been recognised by
researchers as an alternative data source for drug utilisation stud-
ies [6,13–15]. Pharmacy dispensing databases contain records of all
dispensings regardless of subsidisation status, as well as patient
information. This is a signiﬁcant advantage, as it removes a sub-
stantial source of bias.
There are a number of challenges with using pharmacy dispens-
ing databases as the primary data source, however. Pharmacies in
New Zealand operate independently of each other, and do not pool
data (except with Pharms). This makes data collection difﬁcult, as
data have to be obtained from each pharmacy separately. It can
also require extremely complicated sampling frames, as pharma-
cies can vary considerably in their client base. Patients often use
multiple pharmacies, which means that the records for a patient
in any one pharmacy may be incomplete [13]. Pharmacy dispens-
ing databases do not generally include information diagnosis to
dispensing, and do not reliably include non-prescription medicines
sold ‘over-the-counter’.
This is a common scenario internationally. There are a limited
number of places with systems for collecting comprehensive dis-
pensing data from all pharmacies in an area. These systems, when
they are available to drug utilisation researchers, have been tre-
mendously fruitful (see [5,16,14,15]). For the majority of research-
ers, including ourselves, who work in areas without such systems,
other approaches need to be developed.
The Equity in Prescription Medicines Use (EIPMU) study was
undertaken to examine medicines use among groups in the popu-
lation in order to identify whether such use matched the health
needs of those groups. Since the probability of a dispensing being
subsidised was associated with being in one of these population
groups, pharmacy dispensing databases were used instead of
Pharms. We sought to overcome some of the challenges of using
pharmacy dispensing databases by collecting data from all of the
pharmacies in a medium-sized town. Since the town was a sub-
stantial distance from any other town with a pharmacy, it was
hoped that this would provide almost complete capture of medi-
cines dispensings to people from that town and thereby avoid
the possible biases associated with sampling pharmacies. The
EIPMU built upon our experiences of using similar methods in a
smaller, earlier study [13]. However, the process was not
straight-forward.
This paper will describe the methods used in the EIPMU study.
Results from the study will be presented in future papers. We pres-
ent the methods separately here to share our approach and tech-
niques with other researchers considering using unlinked
pharmacy databases in their drug utilisation research.2. Methods
The EIPMU study took place in Gisborne, a town servicing the
Gisborne Region in the north east of New Zealand. The Gisborne
Region has a population of 44,463 people, of which 41,922 (94%)
live in Gisborne city [17]. This region was chosen as the study cen-
tre because of the following:
 It was geographically isolated, with the nearest pharmacy out-
side the district being more than an hour’s drive away from
any other pharmacy in the Region. We could therefore be con-
ﬁdent that almost all of the dispensings to the Region’s inhabit-
ants were provided by the Region’s pharmacies.
 The Gisborne Region had a high proportion of Ma¯ori (44%), the
indigenous people of New Zealand. It also had a mix of people
across the spectrum of socioeconomic positions. This improved
our ability to examine equity issues by ethnicity and socioeco-
nomic deprivation.
The study covered the year 1 October 2005 to 30 September
2006 inclusive. Ethical approval for the study was granted by a
Ministry of Health accredited ethics committee.2.1. Data collection
Data were collected from all eight of Gisborne’s community
pharmacies. Records of outpatient dispensings from the hospital
pharmacy were also obtained. Community pharmacies all used
either the L.O.T.S [18] or Toniq [19] dispensing systems, while
the hospital pharmacy used a bespoke-system. The data from com-
munity pharmacies were collected by physically accessing the
computer system and downloading the data from the pharmacy’s
dispensing software. The data collected included (but were not
limited to):
 Patient demographics, including name, date of birth, gender,
address and health system identiﬁer (National Health Index,
described below).
 Details about the dispensed medicine, such as the medicine,
amount dispensed and medicine strength.
 Financial information about the dispensing, including the cost
to the patient, the amount paid by the Government, any fees
associated with the dispensing and any healthcare concessions
applied.
A patient’s ﬁrst initial, surname and address must be recorded
for every dispensing by a pharmacy under the Medicines Regula-
tions (1984). Date of birth is also required for patients under the
age of 13. This is regardless of whether the medicine being dis-
pensed is subsidised or not. Emergency contraception dispensings
are an exception to this, where the patient can request that per-
sonal information not be recorded.
The data ﬁles were encrypted immediately at the pharmacy to
ensure the conﬁdentiality of the data. Data from the hospital phar-
macy were provided electronically by their staff, and provided less
ﬁnancial information than the data from the community
pharmacies.2.2. Record matching
Previous research has shown that people often patronise more
than one pharmacy [13]. This meant that individuals had to be
identiﬁed across pharmacy datasets. New Zealand has a health sys-
tem identiﬁer (the National Health Index, or NHI) which is as-
signed to a person at ﬁrst contact with the health system
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would not be adequate to match people across pharmacies
because:
 The NHI is supposedly unique to an individual and each person
should only have one. However, some people have more than
one and different NHIs are sometimes recorded in different
pharmacies. Checking of NHIs revealed that 7% of NHIs (10%
of records) recorded were instances where the same person
had multiple NHIs.
 Pharmacists in New Zealand are not required to record the
health system identiﬁer, although most do. Eighty-eight percent
of the records from the study pharmacies had an NHI recorded.
 A preliminary check revealed that 2% of the NHIs (4% of records)
recorded did not pass the check algorithm for determining
whether an NHI is of a valid form, or was used for several differ-
ent patients.
Taken together, the above indicated that matching on NHI alone
would be unwise. We therefore decided to use a probabilistic
matching process, combining the patient information from all of
the pharmacies and treating it as a de-duplication problem. It is
not uncommon for people of non-European ethnicities, particularly
Ma¯ori and Paciﬁc people, to use both their given names and an
anglicised version. We therefore decided to manually review all
pairs to gain some insight into any issues this might cause with
de-duplication. The steps of this process are outlined below.
Step 1 – Initial probabilistic de-duplication
A dataset of unique combinations of NHI, name, date of birth
and gender was created. This initial dataset was then de-dupli-
cated using the above variables with the freely-available software
package LinkPlus [20]. LinkPlus employs a probabilistic Expecta-
tion Maximisation (EM) algorithm to assign weightings based on
the similarity between two records, accounting for name frequency
in the dataset [21].
The matched pairs of records output by LinkPlus were manually
reviewed by two study team members. Deﬁnite matches and non-
matches were marked as such. Uncertain matches were treated as
non-matches. Matched records belonging to the same person were
assigned a computer-generated unique identiﬁer. Gender and
dates of birth which had been missing from a person record were
ﬁlled in if that information was available from another record
which had been deﬁnitely matched.
Step 2 – Initial linkage to the NHI dataset
Once the initial de-duplication step had completed, the initial
unique person combinations were sent to the Information Direc-
torate of the Ministry of Health1 (ID) for linking to the NHI database.
The ID is a Government agency which maintains many of the health
information databases in New Zealand. This includes the NHI data-
base, which contains a list of NHIs and demographic information
about the people they belong to. This demographic information in-
cludes the person’s name, date of birth, gender, ethnicity, socioeco-
nomic deprivation and address.
Records from the EIPMU dataset were matched to the NHI data-
base by ID staff using a direct matching algorithm based on name,
date of birth, gender and NHI (if available). The records which were
successfully matched were then returned augmented with name,
date of birth, gender and NHI data from the NHI. This additional
information from the NHI was then used to ﬁll in missing data
from the pharmacy records and disambiguate inconsistent data
(such as when two records obviously referring to the same person
had different dates of birth). The ﬁlling in of missing data and cor-1 Formerly the New Zealand Health Information Service, or NZHIS.recting inconsistent records was made possible through the use of
the unique person identiﬁers assigned in Step 1.
Step 3 – Second probabilistic de-duplication
The de-duplication process of Step 1was repeated using the aug-
mented person records from Step 2. Matched records belonging to
the same person were assigned a new unique identiﬁer. Re-running
the de-duplication process on the augmented records was per-
formed to maximise de-duplication yield by increasing the amount
and quality of the information available to the de-duplication
algorithm.
Step 4 – Second linkage to the NHI dataset
The records from Step 3 were sent to the ID, where the ID again
matched the EIPMU records to those in the NHI database using the
methods described in Step 2. The records were returned aug-
mented with name, date of birth, gender, NHI, ethnicity, address
and date of death from the NHI database. The primary purpose of
this Step was not to improve the de-duplication quality, but to ob-
tain patient information such as ethnicity, which is not recorded in
pharmacy dispensing databases.
2.3. Assigning socioeconomic deprivation ranks
A key aim of the EIPMU study was to investigate howmedicines
use varied by socioeconomic deprivation. We used the NZ Depriva-
tion Index (NZDep2006, the 2006 version) as our measure of socio-
economic deprivation [22,23]. NZDep2006 is a small area measure
of material socioeconomic deprivation which is widely-used in
New Zealand and has been validated in previous studies [23–25].
The NZDep2006 assigns a deprivation ranking to a small area based
on certain demographics of the area residents. In order to assign a
NZDep2006 ranking to an individual it is necessary to ascertain
which small area they reside in. Unlike countries such as the Uni-
ted Kingdom, New Zealand does not have post-codes which pre-
cisely locate an address. The individual’s whole address therefore
needs to be parsed and placed within the correct small area.
Community pharmacies in New Zealand routinely record pa-
tient addresses. The addresses are recorded for use by the people
working in the pharmacy, however, and not for automated pro-
cessing by computers. The formatting of addresses therefore varies
tremendously between, and often within, pharmacies. This pre-
sented the challenge of geo-locating these addresses to the correct
small area. The process we followed is outlined below.
Step 1 – Address standardisation
The address for each person was converted into a standard form
which could then be matched to an area. This process was per-
formed using the address standardisation routines of the Freely
Available Biomedical Record Linkage programme (FEBRL) version
0.4 [26]. FEBRL uses Hidden Markov Models (HMM) to ‘learn’ pat-
terns of address formatting [27]. This allows the HMM to be trained
with a subset of addresses and then used to output standardised ad-
dresses when applied to the complete set. HMMs are able to gener-
alise to novel input based on the rules learned from the training set.
An HMM was trained for each pharmacy, as there was substan-
tial variation in the formatting of addresses between pharmacies.
Each HMM was trained with an initial set of 250 unique addresses
from that pharmacy. When these addresses were being output to
the correct format, the HMM was applied to the complete list of
unique addresses from the pharmacy. The quality of the output for-
matting was checked and the ﬁrst few records which were not cor-
rectly formatted were added to the training set. The lookup tables
for street and institution names were also updated if needed. This
process was repeated until the accuracy of the HMM could no long-
er be improved. Typically this process led to output which was all
in the correct format with a training set of between 300 and 600
records. At worst, the HMM was unable to correctly standardise
one or two addresses.
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Once the addresses had been standardised, they were matched
electronically to a small area through a concordance list which had
been obtained from Statistics NZ [28]. Not all addresses gave sufﬁ-
cient detail to automatically match through the concordance list,
and some addresses could apply to several places. For example,
institutions and farm names were often recorded, and the study
area had three geographically-distinct Main Streets. The addresses
for such records were manually determined if possible through
searches of the web (Google Maps, Google, the online Regional
Council rates database) and telephone books for the area.
Step 3 – Assignment of deprivation ranks
Once an address had been assigned to a speciﬁc area, the person
was assigned the deprivation rank for that area. If the person had
several different addresses, the mean of the deprivation ranks for
each unique address was assigned.2.4. Medicines coding
Pharmacy dispensing databases in New Zealand contain infor-
mation on the name (brand and generic), strength and quantity
of the medicine dispensed. They also contain a pharmacode, which
is a unique numeric identiﬁer for a speciﬁc drug product. Pharma-
codes are administered by the New Zealand Pharmacy Guild and
every licensed medicine in New Zealand is assigned one.
The databases did not contain an Anatomical Therapeutic
Chemical (ATC) code for each medicine. The ATC [29] is an interna-
tional standard for classifying medicines, and is used extensively in
drug utilisation research. Several colleagues had assigned an ATC
code to all licensed medicines in New Zealand [30]. Using this
information, we were able to create a conversion table so that
pharmacy database pharmacodes could be automatically con-
verted into ATC codes.
The total quantity of medicine dispensed in each dispensing
was calculated in Deﬁned Daily Doses (DDDs) [29] for all medi-
cines which were assigned an ATC code. The DDD system provides
a means for scaling quantities of different medicines into broadly
equivalent units whilst accounting for the relative potencies of
the active ingredients. Each record had the total number of DDDs
contributed by that dispensing calculated when possible.
Compounded medicines (that is, medicines made or mixed by
the pharmacist) were not ATC or DDD coded.3. Results
3.1. Data collection
A total of 654,129 dispensing records were obtained. Dispen-
sings which were not to individuals (such as those for doctor’s sup-
plies or to institutions), as well as those for animals, service fees or
over-the-counter sales were removed from the dataset. This left
625,288 (96%) dispensing records. After record matching, a further
6024 (1%) records were removed because the individuals did not
reside in the study area. This left 619,264 (95% of original total)
dispensing records for analysis.
Unless otherwise stated, individuals residing outside the study
area are excluded from the ﬁgures presented in these analyses.Table 1
Improvement in age, gender and NHI coverage resulting from record matching.
Demographic Raw data Post record matching Improvement (%)
n % n %
Age 575,130 93 614,069 99 7
Gender 493,844 80 608,126 98 23
NHI 559,946 90 603,502 97 83.2. Record matching
Initially, 54,484 individuals were identiﬁed through unique
combinations of NHI, name, date of birth and gender. This number
was reduced in Step 1 to 39,100 individuals, a reduction of 28%.
After receiving additional information through linkage to the NHIdatabase, 38,027 individuals were identiﬁed in Step 3. This was a
3% improvement.
Matching to the NHI database in Step 2 was highly successful,
with 44,395 (81%) of the records sent matched. After the integra-
tion of the de-duplication process results from Step 3, 35,455
(93%) of the records sent were matched to a NHI record.
Table 1 shows the effect of the record matching process on data
coverage in dispensing records for age, gender and NHI. Age and
NHI coverage were already high in the raw pharmacy data. Record
matching only led to modest improvements, although it should be
noted that the NHIs in the post record matching ﬁgure had been
conﬁrmed to match a record in the NHI dataset, whereas those in
the raw pharmacy data had not. Gender was less well-recorded
in the raw pharmacy data, but record matching dramatically im-
proved the coverage achieved.
3.3. Assigning socioeconomic deprivation ranks
Of the 33,375 unique addresses recorded, 1386 (4%) were ad-
judged impossible to assign to an area due to lack of information
(e.g. ‘Gisborne’) or being ambiguous (e.g. ‘123 Main Road’, where
there are several Main Roads in the Gisborne region with that
street number). A total of 30,972 (93%) were able to be matched
to an area. This led to deprivation ranks being assigned for
36,048 (95%) individuals after record matching had taken place.
3.4. Medicines coding
ATC codes were assigned to 613,490 (99%) of the dispensing re-
cords. Of the 5774 (1%) not assigned, 2579 (45%) were com-
pounded items (i.e. items such as creams made up by the
pharmacist). The DDD was able to be calculated for 561,223
(91%) dispensing records. Of the 58,041 (9%) not assigned, 52,186
(90%) did not have a DDD for that medicine in the ATC classiﬁca-
tion, and 5774 (10%) could not be assigned because no ATC was
able to be assigned to the medicine. The remaining 81 (0%) dis-
pensing records could not be assigned a DDD because there was
insufﬁcient information on formulation strength.
3.5. Data coverage
The ultimate data coverage for the key variables of interest is
summarised in Table 2. Coverage for demographic variables was
very high, with 88% of individuals and 93% of dispensing records
containing information on all four demographic variables. Some
clustering was evident when information was missing for more
than one variable. Missing data for both the ethnicity and age vari-
ables was the most common combination, with 37% of individuals
with missing data having information for both those variables
missing. The next most common combination was ethnicity and
gender (24%), followed by age and gender (15%). Overall, two per-
cent of the individuals with missing demographic information had
missing data for only one variable.
ATC coverage was extremely high, with very good total DDD
coverage. The ﬁnal ﬁgure for dispensing records with complete
person and drug information understates the actual success of this
process. Not all ATC categories have a DDD to assign. When re-
Table 2
Summary of demographic and medicine data coverage
Dispensings Individuals
n % n %
Total 619,264 38,027
Demographic
Age 614,069 99 36,283 95
Gender 608,126 98 36,907 97
Ethnicity 598,305 97 34,931 92
Socioeconomic deprivation 595,348 96 36,048 95
All present 576,661 93 33,275 88
Medicine
ATC 613,490 99
Total DDD 561,223 91
Complete 522,563 84
986 S. Horsburgh et al. / Journal of Biomedical Informatics 43 (2010) 982–987calculated using only the ATC categories where a DDD was assign-
able, 93% of dispensing records had complete person and drug
information.
4. Discussion
This paper has described the methods we used to obtain com-
prehensive data on medicines dispensings directly from pharma-
cies. In particular, it has focussed on three key challenges that
we encountered in using this approach: matching individuals
across the different pharmacies, obtaining an area deprivation
measure from the raw addresses recorded in the pharmacy dat-
abases, and coding the medicines information into standard inter-
national classiﬁcations. The methods used have resulted in a rich
dataset with which to examine a wide range of drug utilisation
and access research questions. Data coverage was very high for pa-
tient demographics, and good for standardised medicines classiﬁ-
cation. With the improvement in NHI coverage as a result of the
record matching process, the dataset also holds potential for future
pharmacoepidemiological research through linkage to other health
datasets (such as hospitalisations and accident insurance claims).
A key limitation of the methods described here was that they
were very time-consuming. The collection of the data was the least
intensive part, and could easily be performed by pharmacy staff.
The subsequent data processing and cleaning accounted for the
majority of the effort due to the large amount of manual review
and intervention required because of inconsistencies and errors
in patient information. This is to be expected; dispensing databases
are used to run a pharmacy, not support the needs of researchers
[31]. Inconsistencies in this information are of little consequence
in the daily operation of a pharmacy, because staff are easily able
to deal with them. Information on the medicines themselves and
their cost tended to be more consistently recorded, as these are
automatically generated by the dispensing software itself and are
required for reimbursement of subsidised medicines costs.
There is an argument to be made for the standardisation of
patient information elements and their recording in pharmacy dat-
abases. However, enforcing such standardisation in dispensing
software comes at the cost of hindering pharmacist workﬂow.
Anecdotal evidence from dispensing software manufacturers sug-
gests that pharmacists often turn off features designed to improve
data entry (such as checks to ensure that an entered NHI is in a va-
lid format) because they are seen as annoying interruptions. At a
minimum, improving NHI coverage and quality would signiﬁcantly
reduce the effort needed to use pharmacy databases for research.
There have been some moves in New Zealand towards improv-
ing the coverage and quality of NHI recording in pharmacy
dispensing databases as part of eHealth initiatives [10], given the
role of the NHI in linking information about a patient across the
health system. There is a requirement to have NHIs recorded on90% of the dispensings submitted for Government reimbursement
(Kathy Blake, Ministry of Health Sector Services, personal commu-
nication, 3 February 2010), but pharmacists are not required to
provide the NHI if it is not recorded and there is no checking of
the accuracy of these NHIs by the Ministry of Health beyond ensur-
ing that they are in the correct format. An incorrectly entered NHI
with the correct format, or one referring to the wrong patient, will
not be detected. There is therefore little real incentive for pharma-
cies to improve their recording of NHIs, and little feedback avail-
able for them to correct errors.
An important goal of this study has been to automate the meth-
ods we developed for processing and cleaning the pharmacy dis-
pensing data. This has to a large extent been achieved. The
coding of medicines from dispensing databases has been auto-
mated, as has much of the record cleaning. The trained HMMs
are re-usable for the Gisborne area should the study be repeated
there, and should generalise with minimal re-training to other
areas. The main point in the process still requiring a reasonable
time investment is the matching of patient records across pharma-
cies. This has the potential to be automated by selecting threshold
scores for the automatic assigning of match and non-match status,
and then undertaking a manual review of the subset of records be-
tween these thresholds. Such an approach was not used in this
study, as we wanted to create a dataset as close as possible to being
correctly de-duplicated. Improvements in NHI coverage and accu-
racy would make this process substantially more efﬁcient.
The challenges faced in generating this dataset are not unique,
and in many ways reﬂect those encountered in the initial stages
of other now well-established automated pharmacy dispensing
data systems [16,15]. The availability (or development) of a reli-
able personal healthcare identiﬁer in pharmacy databases was a
critical part of making these systems viable on an on-going basis.
While the processes used in this study could be repeated reason-
ably efﬁciently, it is difﬁcult to see them as being viable on a
long-term (or ultimately national) scale with the current coverage
and quality of NHIs in the pharmacy databases. The consistent and
accurate recording of a personal healthcare identiﬁer in pharmacy
dispensing databases are key requirements before a viable, long-
term automated pharmacy dispensing data system can be devel-
oped and deployed. In the New Zealand context, this means that
pharmacies need to be required to record accurate NHIs in their
dispensing databases, or incentivised to do so.Summary table
What was already known on the topic:
 Pharmacy dispensing databases can provide a rich source of
medicines use and pharmacoepidemiological data free of many
of the biases inherent in administrative databases.
 Pharmacy dispensing data are often not collated, making it dif-
ﬁcult to obtain comprehensive capture of drug exposure.
 Pharmacy dispensing databases are primarily intended for day-
to-day use in a pharmacy. It can take a substantial amount of
processing to make the data usable for research purposes.
What this study added to our knowledge:
 This study has described methods for collecting and processing
key information from pharmacy dispensing databases which
were successful in New Zealand.
 These methods should be broadly transferrable to other coun-
tries where comprehensive medicines use data are needed,
but data from pharmacy databases are not shared and centrally
accessible.
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